H&H Secures US$330 Million Syndicated Refinancing Package
Complete. Here is the key summaryHealth and Happiness (H&H) International Holdings secured a US$330 million syndicated refinancing package, consisting of US$320 million in term loans and a US$10 million revolving credit line. Led by HSBC, the facilities aim to repay existing debt and fund working capital, with an initial tenor of 36 months. The deal is subject to NDRC registration and includes a change-of-control clause.
Health and Happiness (H&H) International Holdings ( (HK:1112) ) just unveiled an announcement.
Health and Happiness (H&H) International Holdings Limited has arranged new syndicated refinancing facilities totalling about US$330 million, comprising term loans of roughly US$320 million and a US$10 million revolving credit line. The package, led by The Hongkong and Shanghai Banking Corporation Limited, remains subject to standard conditions including registration with China’s National Development and Reform Commission.
Proceeds from the term loans will repay existing offshore renminbi and syndicated facilities, cover associated refinancing costs and later support general corporate purposes, while the revolving line will fund working capital. Both facilities carry an initial tenor of 36 months, with potential extension to 60 months, and include a change-of-control clause that triggers cancellation and immediate repayment if controlling shareholder Mr. Luo Fei and his family cease to hold the largest voting stake.
The most recent analyst rating on (HK:1112) stock is a Buy
with a HK$20.90 price target.
To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock,
see the HK:1112 Stock Forecast page.
More about Health and Happiness (H&H) International Holdings
Health and Happiness (H&H) International Holdings Limited is a Hong Kong-listed consumer health group focused on nutrition and wellness products, operating through subsidiaries including Biostime Healthy Australia Investment. The company targets global markets with a portfolio spanning infant nutrition, adult supplements and related health-focused offerings.
Average Trading Volume: 2,504,676
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.81B
